205 related articles for article (PubMed ID: 15711047)
1. Extraintestinal manifestations of Crohn's disease.
Juillerat P; Mottet C; Froehlich F; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
Digestion; 2005; 71(1):31-6. PubMed ID: 15711047
[TBL] [Abstract][Full Text] [Related]
2. Extraintestinal manifestations of Crohn's disease.
Juillerat P; Mottet C; Pittet V; Froehlich F; Felley C; Gonvers JJ; Vader JP; Michetti P
Digestion; 2007; 76(2):141-8. PubMed ID: 18239406
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
4. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
5. [Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery].
Nascimbeni R; Di Fabio F; Lanzini A; Lanzarotto F; Ricci C; Casella C; Salerni B
Ann Ital Chir; 2009; 80(4):293-8. PubMed ID: 19967888
[TBL] [Abstract][Full Text] [Related]
6. [Extraintestinal complications in patients with ulcerative colitis].
Oshitani N; Watanabe K; Nakamura S; Higuchi K; Arakawa T
Nihon Rinsho; 2005 May; 63(5):874-8. PubMed ID: 15881184
[TBL] [Abstract][Full Text] [Related]
7. [Extraintestinal manifestations of inflammatory bowel disease].
Rogler G; Schölmerich J
Med Klin (Munich); 2004 Mar; 99(3):123-30. PubMed ID: 15024484
[TBL] [Abstract][Full Text] [Related]
8. The effect of infliximab on extraintestinal manifestations of Crohn's disease.
Kaufman I; Caspi D; Yeshurun D; Dotan I; Yaron M; Elkayam O
Rheumatol Int; 2005 Aug; 25(6):406-10. PubMed ID: 15309501
[TBL] [Abstract][Full Text] [Related]
9. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.
Peyrin-Biroulet L; Loftus EV; Colombel JF; Sandborn WJ
Inflamm Bowel Dis; 2011 Jan; 17(1):471-8. PubMed ID: 20725943
[TBL] [Abstract][Full Text] [Related]
10. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
Carp JM; Onuma E; Das K; Gottlieb AB
Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
[TBL] [Abstract][Full Text] [Related]
11. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications.
Rankin GB; Watts HD; Melnyk CS; Kelley ML
Gastroenterology; 1979 Oct; 77(4 Pt 2):914-20. PubMed ID: 467943
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for treatment with infliximab for Crohn's disease.
Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
[TBL] [Abstract][Full Text] [Related]
13. Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?
Walker D; Orchard T
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S200-1. PubMed ID: 18816647
[No Abstract] [Full Text] [Related]
14. Efficacy of adalimumab for the treatment of extraintestinal manifestations of Crohn's disease.
Barreiro-de-Acosta M; Lorenzo A; Domínguez-Muñoz JE
Rev Esp Enferm Dig; 2012 Sep; 104(9):468-72. PubMed ID: 23130854
[TBL] [Abstract][Full Text] [Related]
15. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.
Mottet C; Vader JP; Felley C; Froehlich F; Gonvers JJ; Juillerat P; Stockbrügger R; Angelucci E; Seibold F; Michetti P; Pittet V;
J Crohns Colitis; 2009 Dec; 3(4):257-63. PubMed ID: 21172284
[TBL] [Abstract][Full Text] [Related]
16. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
17. [Pyoderma gangrenosum, a nonintestinal manifestation of Lesniowski-Crohn's disease in a 15 years old girl].
Müller L; Bala G; Kuczyńska R; Czerwionka-Szaflarska M
Med Wieku Rozwoj; 2006; 10(2):463-73. PubMed ID: 16825717
[TBL] [Abstract][Full Text] [Related]
18. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
[TBL] [Abstract][Full Text] [Related]
19. Treatment of extraintestinal manifestations in inflammatory bowel disease.
Lakatos PL; Lakatos L; Kiss LS; Peyrin-Biroulet L; Schoepfer A; Vavricka S
Digestion; 2012; 86 Suppl 1():28-35. PubMed ID: 23051724
[TBL] [Abstract][Full Text] [Related]
20. [Crohn's disease, primary sclerosing cholangitis and antiphospholipid syndrome: an uncommon association].
Romdhane H; Karoui S; Serghini M; Boubaker J; Filali A
Tunis Med; 2009 May; 87(5):349-51. PubMed ID: 19927768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
